Franklin Resources Inc. raised its stake in DocGo Inc. (NASDAQ:DCGO - Free Report) by 14.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,370,819 shares of the company's stock after buying an additional 171,733 shares during the quarter. Franklin Resources Inc. owned about 1.34% of DocGo worth $5,812,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of DCGO. Centiva Capital LP acquired a new position in DocGo during the third quarter worth $43,000. Prudential Financial Inc. acquired a new stake in DocGo during the 4th quarter worth approximately $55,000. Royce & Associates LP purchased a new position in DocGo in the 4th quarter valued at approximately $64,000. Intech Investment Management LLC grew its stake in DocGo by 76.7% during the 4th quarter. Intech Investment Management LLC now owns 32,834 shares of the company's stock worth $139,000 after purchasing an additional 14,247 shares in the last quarter. Finally, SG Americas Securities LLC increased its stake in shares of DocGo by 12.9% during the fourth quarter. SG Americas Securities LLC now owns 43,052 shares of the company's stock worth $183,000 after buying an additional 4,905 shares during the period. Hedge funds and other institutional investors own 56.44% of the company's stock.
DocGo Stock Performance
DocGo stock traded down $0.12 during midday trading on Tuesday, reaching $2.24. The stock had a trading volume of 399,377 shares, compared to its average volume of 749,659. The stock's 50-day simple moving average is $3.47 and its 200 day simple moving average is $3.83. The stock has a market capitalization of $227.93 million, a PE ratio of 7.98, a price-to-earnings-growth ratio of 14.16 and a beta of 1.12. DocGo Inc. has a twelve month low of $2.16 and a twelve month high of $5.68.
Wall Street Analyst Weigh In
A number of analysts have weighed in on DCGO shares. Stifel Nicolaus cut their price target on DocGo from $6.50 to $5.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. Needham & Company LLC reissued a "buy" rating and set a $4.00 price objective on shares of DocGo in a research report on Tuesday, April 8th. Finally, Deutsche Bank Aktiengesellschaft lowered DocGo from a "buy" rating to a "hold" rating and dropped their target price for the company from $5.00 to $2.85 in a report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $4.89.
Get Our Latest Research Report on DocGo
About DocGo
(
Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
See Also
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
